Regardless of these discrepancies, in all cases, AR promotes the activation of FGFR in prostate cancer cells, which results in phosphorylation of FRS2 and activation of the downstream Ras/Raf/MEK/ERK signaling pathway. This evidence concerns the gene AR and prostate carcinoma.